TINTAGEL, England (March 2, 2011) – Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it will exhibit its Maybridge Fragment collections and present a related scientific poster, “A High Throughput Technique for Rapid Measurement of Fragment Solubility,” during Fragments III, the 3rd annual RSC-BMCS Fragment-Based Drug Discovery conference (Stevenage, England, March 7-8).
The poster describes the use of the Stem Clarity solubility station to experimentally validate fragment solubility values in both DMSO (200mM) and aqueous phosphate buffer. Such analyses have been used to affirm compound quality and further enhance the success rate of hits generated by the Maybridge Ro3 Fragment collection. Scientists from Maybridge will be available on stand E at the Stevenage Fragments III meeting to discuss the work presented on the poster and other aspects of fragment-based drug discovery.
Maybridge compound libraries represent a gold standard in molecular fragment libraries and include the Ro3 Diversity library, Fragment collection, Bromo-, Fluoro- and Pre-Fragment collections. Maybridge prides itself on having the in-house scientific expertise to provide the highest-quality products and services for fragment-based drug-discovery needs.
For more information on the poster please visit:
http://www.maybridge.com/Images/pdfs/MB_poster_GlobalC_09_V02.pdf.
For further information on Maybridge products and services, please visit: www.maybridge.com.
About Maybridge
Maybridge, part of Thermo Fisher Scientific, is well known for providing highly innovative drug-like molecules and screening compounds for drug discovery and development. With products available for both lab and development scale, they specialize in producing new heterocyclic and phenyl ring-based chemical building blocks, including a unique and expanding range of reactive intermediates. For more information about Maybridge brand products visit www.maybridge.com or call +44 18 40 77 05 67.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of nearly $11 billion, we have approximately 37,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through two premier brands, Thermo Scientific and Fisher Scientific, which offer a unique combination of continuous technology development and the most convenient purchasing options. Our products and services help accelerate the pace of scientific discovery, and solve analytical challenges ranging from complex research to routine testing to field applications. Visit www.thermofisher.com
